reason report
guidanc lower expect asset appear
dress sale
bottom line see fundament decent
guidanc achiev asset pois sale
new ceo transit report guidanc
manag confer call adjust estim reflect
trend rais pt averag
ebitda given view like takeout within month
quarter modest miss ebitda in-lin revenu off-set
margin pressur uk staf issu agenc cost
censu level abl off-set higher wage guidanc
light better lower expect head
quarter amid ceo transit conservat guid
offer solid achiev importantli strong view
ceo transit joey jacob debra osteen former head
behavior competitor op point like shift strategi
aggress capit deploy de novo growth toward
squeez oper valu exist asset like
takeout whole part across inpati outpatient/subst
abus asset ceo osteen express earli view valu
eke see clinic staf shortag payor mix issu
reimburs length stay lo manag medicaid
less relev given geograph busi mix updat
strategi expect ceo may time report
see pois sale whole part new
ceo transit manag confer call new ceo
conduct comprehens oper review includ strateg
altern uk divestitur take privat transact
believ take privat transact could yield multipl
repres upsid current level exhibit
modest miss ebitda in-lin revenu off-set
margin pressur uk staf issu agenc cost
censu level abl off-set higher wage revenu
mm line consensu adj ebitda mm
expect ebitda margin declin bp yoy
bp qoq exhibit
us ss revenu growth would adjust
one-tim mm charg wi claim review
state relat claim transit manag
medicaid program new ceo see clinic staf shortag
payor mix issu reimburs lo manag medicaid
less relev given geograph busi mix us
demand continu strong ss admiss trend bp
compani inform svb leerink llc research
revenu million
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth lt ep compound-annual-growth-rate
year price history/av daili volume mil
pleas refer page import disclosur price chart analyst certif
uk challeng staf agenc cost lower censu
remain though proactiv work uk
govern address headwind despit challeng
ss revenu grew trend bp yoy manag
note discuss nh increas
staf cost part environ nation live wage
make sure reimburs appropri manag
look reduc agenc spend hire perman employe
increas occup also focu bring bed
close retool last year back line certain
under-perform facil may close exhibit
guidanc light better lower expect
head quarter amid ceo transit conservat
guid offer solid achiev guidanc assum
ss us revenu growth ss uk revenu growth drive margin
improv uk year-end exhibit
lower estim reflect trend guidanc
lower ebitda mm vs guidanc mm
estim mm assum top-lin
new ceo point like shift strategi aggress capit
deploy de novo growth toward squeez
oper valu exist asset ceo osteen
express earli view valu eke
decreas bed add year us/ uk
plan open de novo manag set target
leverag ratio year-end
rais pt pt repres ev
ebitda averag low end see like
see fundament decent guidanc achiev
asset pois sale new ceo transit report guidanc
manag confer call adjust estim reflect trend rais pt
averag ebitda given view like takeout within month
quarter modest miss ebitda in-lin revenu off-set margin pressur
uk staf issu agenc cost censu level abl off-set higher
wage guidanc light better lower expect head quarter
amid ceo transit conservat guid offer solid achiev
importantli strong view ceo transit joey jacob debra osteen
former head behavior competitor point like shift strategi aggress
capit deploy de novo growth toward squeez oper valu
exist asset like takeout whole part across inpati
outpatient/subst abus asset ceo osteen express earli view valu
eke see clinic staf shortag payor mix issu reimburs lo
manag medicaid less relev given geograph busi mix
updat strategi expect ceo may coincid report
see pois sale whole part new ceo transit
manag confer call new ceo conduct comprehens oper review
includ strateg altern uk divestitur take privat transact believ
take privat transact could yield multipl repres upsid
current level previou privat equiti pe takeout note avail follow
link link
convers employe stakehold reinforc belief acadia strong
posit recogn work team heard candid feedback
take serious close evalu aspect busi see
opportun also look improv make deliv better perform
highest prioriti drive signific increas sharehold valu time develop
execut strategi leverag strength provid excel care mani patient
come acadia facil help although would expect still work evalu
busi expect provid view strategi futur direct may meantim
look forward engag come week
modest miss ebitda in-lin revenu off-set margin pressur
uk staf issu agenc cost censu level abl off-set higher
wage revenu mm line consensu adj ebitda mm
expect ebitda margin declin bp yoy bp qoq
us ss revenu growth would adjust one-tim mm charg
wi claim review state relat claim transit
manag medicaid program new ceo see clinic staf shortag payor
mix issu reimburs lo manag medicaid less relev given
geograph busi mix us demand continu strong ss admiss trend
bp yoy
compani report svb leerink estim
compani report svb leerink estim
compani report svb leerink estim
uk challeng staf agenc cost lower censu remain though
proactiv work uk govern address headwind despit
challeng ss revenu grew trend bp yoy manag note
discuss nh increas staf cost part environ
nation live wage make sure reimburs appropri
manag look reduc agenc spend hire perman employe increas
occup also focu bring bed close retool last year
back line certain under-perform facil may close
compani report svb leerink estim
uk volum yoy qoq
compani report svb leerink estim
guidanc light better lower expect head quarter
amid ceo transit conservat guid offer solid achiev
guidanc assum ss us revenu growth ss uk revenu growth drive margin
improv uk year-end
compani guidanc leerink compens compani guidanc leerink acadia healthcar compani inc
lower estim reflect trend guidanc lower ebitda
mm vs guidanc mm estim mm assum
top-lin ebitda growth
consensussvb leerinkconsensussvb leerinkconsensussvb leerinkconsensussvb leerinkconsensussvb leerinkconsensussvb oper leas net per patient per patient acadia healthcar compani inc
lower ebitda mm mm
lower ebitda mm mm
svb leerink estim note number may sum total due round
new ceo point like shift strategi aggress capit deploy de novo
 growth toward squeez oper valu exist asset
ceo osteen express earli view valu eke decreas
bed add year us/ uk plan open de novo
manag set target leverag ratio year-end
driver svb leerink ss growth uk ss growth driven volum pricingramp de de novo facil expens bp improvementuk censu staf issu continu moder svb leerink svb leerink ss growth uk ss growth driven volum pricingramp de de novo facil expens bp improvementuk censu staf issu continu moder svb leerink acadia healthcar compani inc
rais pt pt repres ev ebitda averag
low end see like privat equiti takeout rang
trade ebitda consensu view
svb leerink estim factset
pt contempl ev/ebitda averag ebitda
primari valuat methodolog base ev/ebitda rel rel
ev/ebitda also track function compani histori hospit group
averag assess potenti ev/ebitda expans next month base
forward forecast contempl underli fundament implic healthcar
reform dcf valuat leverag forward forecast wacc termin
growth rate point potenti multipl expans along sector company-
specif catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
market perform price target base ev/ebitda
downsid risk valuat includ
risk higher acquisit multipl slow acquisit driven growth
financi posit result oper
uk reli publicli fund entiti unit kingdom
revenu loss reduct fund chang procur method
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom expensessalari rent leas oper ebitda depreci oper non-oper ebit net interest incom tax incom yoy net incom averag share million dilut dilut yoy non-recur item metricsrevenu growth expense/net leas expense/net opex/net acadia healthcar compani inc
hospit usinpati chang chang chang hospit ukinpati chang chang revenu chang acadia healthcar compani inc
